Canadian Lung Association

American Lung Association Invests in Critical Work to Create Universal Flu Shot

Retrieved on: 
Wednesday, October 4, 2023
Partnership, American Lung Association, Texas Biomedical Research Institute, Disbursement Acceleration Program, Research, Doctor of Philosophy, Canadian Lung Association, Government, CDC, Death, Influenza, Korea Disease Control and Prevention Agency, Pharmaceutical industry, Vaccine

CHICAGO, Oct. 4, 2023 /PRNewswire/ -- Today, the American Lung Association Research Institute announced a three-year, $500,000 grant to Texas Biomedical Research Institute to help accelerate its efforts to develop a universal flu vaccine. This is the first Accelerator Program investment that the Lung Association has made since it launched the American Lung Association Research Institute earlier this year.

Key Points: 
  • CHICAGO, Oct. 4, 2023 /PRNewswire/ -- Today, the American Lung Association Research Institute announced a three-year, $500,000 grant to Texas Biomedical Research Institute to help accelerate its efforts to develop a universal flu vaccine.
  • This is the first Accelerator Program investment that the Lung Association has made since it launched the American Lung Association Research Institute earlier this year.
  • "This partnership with the American Lung Association enables us to move quickly with this vaccine research."
  • This funding was provided by the American Lung Association Research Institute, which launched in March to address the urgent and critical lung health challenges in our country.

American Lung Association Provides Guidance for Schools to Stock Lifesaving Asthma Medication

Retrieved on: 
Wednesday, August 30, 2023
School, Asthma, American Lung Association, Parent, Policy, Standing, Management, Student, Canadian Lung Association, Periodic breathing, Family, Safety, Legislation, Nursing, Pharmaceutical industry

To help school administrators and staff provide care for students with asthma this school year, the American Lung Association announced a new, free online course, Stock Asthma Medication: Implementation Guidance for Schools.

Key Points: 
  • To help school administrators and staff provide care for students with asthma this school year, the American Lung Association announced a new, free online course, Stock Asthma Medication: Implementation Guidance for Schools.
  • Stock Asthma Medication: Implementation Guidance for Schools is a free, one-hour interactive online course designed for designated (licensed and unlicensed) school personnel who administer stock quick-relief asthma medication and stakeholders seeking to understand and implement relevant legislation, policies or programs.
  • The course will teach attendees to:
    Identify the benefits of implementing a stock quick-relief asthma medication policy in schools.
  • The Lung Association is also hosting a webinar to inform people about possible solutions to overcome common barriers to implementing stock asthma medication programs in schools on September 20 at 3 p.m. CT.

One Million People Complete Lifesaving Quiz for Lung Cancer Screening

Retrieved on: 
Thursday, June 1, 2023
American Lung Association, Council, Ad Council, Lung cancer, US, Scan, Canadian Lung Association, Smoke, Diagnosis, USPSTF, Medical imaging

CHICAGO, June 1, 2023 /PRNewswire/ -- The American Lung Association today announced it reached an important milestone in the efforts to end lung cancer. As a part of the "Saved by the Scan" campaign, more than one million people, 1,051,303 as of April 2023, have completed an online quiz to determine if they are eligible for lifesaving lung cancer screening. Twenty-five percent of those who have taken the quiz since the campaign's inception were found to be high-risk for lung cancer and eligible for screening.

Key Points: 
  • American Lung Association's 'Saved by the Scan' campaign marks significant milestone, celebrates lives saved by lung cancer screening
    CHICAGO, June 1, 2023 /PRNewswire/ -- The American Lung Association today announced it reached an important milestone in the efforts to end lung cancer.
  • As a part of the "Saved by the Scan" campaign, more than one million people, 1,051,303 as of April 2023, have completed an online quiz to determine if they are eligible for lifesaving lung cancer screening.
  • Twenty-five percent of those who have taken the quiz since the campaign's inception were found to be high-risk for lung cancer and eligible for screening.
  • The American Lung Association partnered with the Ad Council to launch "Saved by The Scan" in 2017 to educate people about lifesaving lung cancer screening and encourage them to take a 2-minute quiz to see if they are eligible.

New survey shows Canadians want Big Tobacco to pay for tobacco reduction efforts

Retrieved on: 
Monday, May 29, 2023
Canadian Lung Association, Canadian Cancer Society, Smoker, Japan, American Cancer Society Cancer Action Network, Ipsos, Public, Parent, Tobacco, Policy, Stroke, Respiratory disease, Cancer, British Columbia v Imperial Tobacco Canada Ltd, American Cancer Society, Government, Organization, Outline, Big Tobacco, Health, Letter, Smoking, Death, Premier, Disease, Rothmans

The Canadian Cancer Society, Canadian Lung Association and Heart & Stroke are calling for significant tobacco reduction measures to be included in a major lawsuit settlement currently under negotiation with Big Tobacco companies.

Key Points: 
  • The Canadian Cancer Society, Canadian Lung Association and Heart & Stroke are calling for significant tobacco reduction measures to be included in a major lawsuit settlement currently under negotiation with Big Tobacco companies.
  • "We are deeply concerned that the negotiations are being held behind closed doors and that tobacco companies are at the table but health organizations are not.
  • The defendants are Imperial Tobacco Canada Ltd, Rothmans, Benson & Hedges Inc, and JTI-MacDonald Corp, as well as their foreign parents.
  • "A settlement must be about forever changing tobacco industry behaviour," says Terry Dean, President and CEO, Canadian Lung Association.

American Lung Association Campaign Aims to Address Lack of Diversity in Clinical Trials, Improve Lung Cancer Care for Black Americans

Retrieved on: 
Wednesday, May 17, 2023
Volunteering, American Lung Association, Gender identity, Education, Clinical trial, Cancer, Lung cancer, Trust, Research, Language, Canadian Lung Association, African Americans, Address, Novartis, Daiichi Sankyo, DEI, Disease, Pharmaceutical industry, Nursing, Genentech, Black, Merk

Black Americans with lung cancer are less likely to be diagnosed at an early stage , less likely to receive surgical treatment , and less likely to receive any treatment at all compared to white Americans.

Key Points: 
  • Black Americans with lung cancer are less likely to be diagnosed at an early stage , less likely to receive surgical treatment , and less likely to receive any treatment at all compared to white Americans.
  • Lung cancer research is moving at a rapid pace, and clinical trials are critical to advancing promising lung cancer treatments.
  • Black Americans are underrepresented in clinical research, so I am working with the American Lung Association to fix that," said Danielle Mitchell, Founder and CEO of Black Women in Clinical Research .
  • Given the disproportionate impact of lung disease on historically underserved communities, the Lung Association embraces diversity as a moral and mission-driven imperative.

Protect Environmental and the American Lung Association Announce National Partnership to Prevent Radon-Induced Lung Cancer

Retrieved on: 
Monday, May 8, 2023
American Lung Association, Partnership, Non-Smokers' Rights Association, Radon, Lung cancer, Canadian Lung Association, Organization, Death, Smoking, Uranium mining

LOUISVILLE, Ky., May 8, 2023 /PRNewswire-PRWeb/ -- Protect Environmental, in conjunction with the American Lung Association, announced today the national partnership between the two organizations to prevent radon-induced lung cancer. The announcement comes during the kickoff of Lung Cancer Action Week, an initiative focused on raising awareness and building support for improved lung health. Exposure to radon is the leading cause of lung cancer among non-smokers, second only to smoking, and is responsible for more than 21,000 annual deaths in the United States.

Key Points: 
  • National strategic partnership formed to save lives by increasing radon awareness, testing, and mitigation in communities throughout the country
    LOUISVILLE, Ky., May 8, 2023 /PRNewswire-PRWeb/ -- Protect Environmental, in conjunction with the American Lung Association, announced today the national partnership between the two organizations to prevent radon-induced lung cancer.
  • The announcement comes during the kickoff of Lung Cancer Action Week , an initiative focused on raising awareness and building support for improved lung health.
  • As part of the national partnership, Protect Environmental will provide its National Radon Risk Search™ tool and offer no-cost professional testing to assist American Lung Association supporters with understanding the radon risk in their communities and homes.
  • "The American Lung Association has been a long-time friend of Protect Environmental, and we are excited to be expanding our relationship through this strategic partnership," said Kyle Hoylman, chief executive officer of Protect Environmental and a member of the American Lung Association's Local Leadership Board in Kentucky.

American Lung Association, Gateway for Cancer Research Partner to Develop Personalized Lung Cancer Vaccine

Retrieved on: 
Wednesday, May 3, 2023
Carcinoma, DNA, Partnership, DNA-directed RNA interference, Canadian Lung Association, American Lung Association, Cancer, Lung cancer, Immunotherapy, Hope, Research, RNA, Lung, Doctor of Philosophy, SCLC, Patient, Physician, ALA, Immune system, Washington University School of Medicine, Diagnosis, Safety, Disease, Pharmaceutical industry, Vaccine, MD, Gateway

 CHICAGO, May 3, 2023 /PRNewswire/ -- Gateway for Cancer Research, a nonprofit organization dedicated to funding transformational early phase cancer clinical trials around the world, today announced a new partnership with the American Lung Association Research Institute. The alliance centers on a funding agreement between Gateway and the Lung Association to advance a personalized vaccine trial that aims to train each patient's immune system to combat small cell lung cancer (SCLC). Spearheaded by Jeffrey Ward, MD, PhD, a medical oncologist at Washington University School of Medicine in St. Louis, Missouri, the trial officially began enrolling patients in spring 2022 for what will be a five-year study. Investigators believe it to be the only ongoing trial integrating a personalized vaccine into first-line therapy for SCLC.

Key Points: 
  • CHICAGO, May 3, 2023 /PRNewswire/ -- Gateway for Cancer Research , a nonprofit organization dedicated to funding transformational early phase cancer clinical trials around the world, today announced a new partnership with the American Lung Association Research Institute .
  • The alliance centers on a funding agreement between Gateway and the Lung Association to advance a personalized vaccine trial that aims to train each patient's immune system to combat small cell lung cancer (SCLC).
  • An aggressive type of lung cancer, SCLC is estimated to account for approximately 14% of all lung cancer diagnoses.
  • Gateway for Cancer Research and the American Lung Association together have contributed $678,668 to support development of the trial vaccine.

New American Lung Association Research Institute to Accelerate High Impact, Lifesaving Lung Health Science

Retrieved on: 
Tuesday, March 21, 2023
COPD, Tobacco Products Scientific Advisory Committee, Pulmonary Vascular Research Institute, Partnership, Asthma, American Lung Association, COVID-19, Lung cancer, Research, Government, Press release, Canadian Lung Association, Respiratory disease, Research institute, Health, Death, National Board of Health and Welfare (Sweden), Pharmaceutical industry

CHICAGO, March 21, 2023 /PRNewswire/ -- More than 34 million Americans live with lung disease. When combined with lung cancer and respiratory diseases like COVID-19 and influenza, lung disease is a leading cause of death in America. To address urgent and critical lung health challenges in our country, the American Lung Association today announced the launch of the American Lung Association Research Institute.

Key Points: 
  • To address urgent and critical lung health challenges in our country, the American Lung Association today announced the launch of the American Lung Association Research Institute .
  • The American Lung Association Research Institute is our answer to this challenge, and we are committed to investing in research, collaborating with experts and empowering scientists to accelerate discovery and innovation," said Harold Wimmer, President and CEO of the American Lung Association.
  • "The Lung Association has long been the trusted champion of lung health research, and the new Research Institute will take our work to end lung disease to the next level."
  • The new American Lung Association Research Institute will:
    Increase Research Investment through the organization's Awards and Grants program to $25 million per year by 2030.

New Program Offers Critical Resources to the 34 million Americans Living with Lung Disease

Retrieved on: 
Tuesday, January 31, 2023
Knowledge, ACRC, American Lung Association, Boehringer Ingelheim, Caregiver, COVID, Patient, Diagnosis, Education, Lung cancer, Chronic obstructive pulmonary disease, Pulmonary fibrosis, Inspiration, COPD, Research, Disease, Asthma, Canadian Lung Association, Residential care, Pharmaceutical industry, Nursing

CHICAGO, Jan. 31, 2023 /PRNewswire/ -- More than 34 million Americans live with chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, lung cancer and other lung diseases. To provide these individuals and their families with critical support, education and access to emerging research like clinical trials, today, the American Lung Association announced the Patient & Caregiver Network.

Key Points: 
  • American Lung Association launches Patient & Caregiver Network to provide support, education and access to research for people with lung disease and their families
    CHICAGO, Jan. 31, 2023 /PRNewswire/ -- More than 34 million Americans live with chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, lung cancer and other lung diseases.
  • To provide these individuals and their families with critical support, education and access to emerging research like clinical trials, today, the American Lung Association announced the Patient & Caregiver Network .
  • Fortunately, new research is resulting in better treatments so that people with lung disease are living longer, healthier lives," said Harold Wimmer, National President and CEO of the American Lung Association.
  • "Our new Patient & Caregiver Network is the go-to resource for anyone living with a lung disease and their families."

COVID-19 Claims 2,000 Lives Per Week; 3 Critical Things Everyone Should Know

Retrieved on: 
Wednesday, January 11, 2023
Well, Chronic kidney disease, Immunodeficiency, Degenerative disease, Ageing, Hospital, COPD, Death, Cystic fibrosis, Public health, Winter, MD, CDC, Overweight, Vaccination, Korea Disease Control and Prevention Agency, COVID-19, American Lung Association, Virus, Risk, High Risk, Canadian Lung Association, Availability, Smoke, Centers for Disease Control and Prevention, Pulmonary hypertension, Interstitial lung disease, Asthma, IV, Diabetes, Vaccine, Diagnosis, Pharmaceutical industry, Pfizer

CHICAGO, Jan. 11, 2023 /PRNewswire/ -- There are still more than 400,000 new COVID-19 cases and 2,500 deaths due to COVID-19 each week, and an average of 5,000 hospitalizations each day in the U.S. COVID-19 continues to be a significant burden in the U.S., so the American Lung Association launched a new campaign today to educate the public on critical information they should know should they experience symptoms that could be COVID-19.

Key Points: 
  • "Most importantly, everyone six months of age and older should be up to date with their COVID-19 vaccination.
  • COVID-19 vaccines are the best step to prevent severe illness and hospitalization," said Albert Rizzo, MD, Chief Medical Officer for the American Lung Association.
  • "However, no vaccine is 100% effective, so there are steps you should take if you are at increased risk for severe COVID-19 and begin experiencing symptoms."
  • Depending on your situation, your healthcare provider may prescribe an antiviral treatment to stop the virus from multiplying within your body.